In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner ...

This is our FDA today. Quack nostrums get approved based on “incredible stories”, while vaccines get dismissed out of hand despite multiple successful RCTs. Our FDA leaders call this “ gold-standard ...

The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.

The U. Food and Drug Administration will not review Moderna's approval application for its influenza vaccine, the company ...

French drugmaker Sanofi ousted CEO Paul Hudson on Thursday ​appointed Belén Garijo, the head of German drugmaker Merck KGaA, ...

In a news release late Tuesday, Moderna said it was blindsided by the FDA’s refusal, which the FDA cited as being due to the design of the company’s Phase 3 trial for its mRNA flu vaccine, dubbed mRNA ...

In today’s issue: The winner and loser of today’s congressional health affordable hearing. A bipartisan agreement to reveal ...

By Bhanvi Satija LONDON, Jan 29 (Reuters) - France's Sanofi, among the world's largest vaccine makers, said on Thursday that its vaccines sales would be "slightly negative" this year, partly due to U.

By Avinash P and Johann M Cherian Feb 12 (Reuters) - European shares hit a record high on Thursday, with luxury and artificial intelligence hardware makers leading gains on positive earnings. The ...

French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from US anti-vaccine ...